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We have directly compared the effect of two types of dextran sulfate with distinct molecular
weights (500 kDa and 5 kDa) on the fusion activity and infectivity of both Sendai and
influenza viruses, two lipid-enveloped viruses that differ in their routes of entry into target
cells. To correlate membrane merging and infectivity MDCK cells were used as targets for
the viruses in both approaches. In either case pronounced inhibition of virus–cell inter-
actions by dextran sulfate was only observed at low pH, even though Sendai virus fuses
maximally at pH 7.4. Although membrane merging could not be fully abolished, the inhibi-
tory effect was always greater when the higher molecular weight dextran sulfate was used.
The presence of this residual fusion activity, that could not be reduced even with high
concentrations of agent, suggests that a limited number of binding sites for dextran sulfate
may exist on the viral envelopes. The compounds also inhibited fusion of bound virions,
and all results could be reproduced using erythrocyte ghosts as target membranes in the
fusion assay, instead of MDCK cells. In agreement with these observations only the infec-
tivity of influenza virus (which requires a low pH-dependent step to enter target cells) was
affected by dextran sulfate, again the higher molecular weight compound showing a more
pronounced inhibitory effect.
KEY WORDS: Influenza; Sendai; membrane fusion; dextran sulfate; infectivity;
inhibition
ABBREVIATIONS: DMEM, Dulbecco’s Modified Eagle Medium; D8, extran 8 kDa;
D 500, dextran 500 kDa; DS 5, dextran sulfate 5 kDa; DS 500, dextran sulfate 500 kDa;
HA, influenza virus hemagglutinin; MDCK–Madin–Darby canine kidney cells; pfu–plaque
forming units; R18, octadecylrhodamine B chloride
INTRODUCTION
All lipid-enveloped viruses enter cells via a membrane fusion event that is usually
dependent on one or more viral envelope proteins. However, there are two distinct
routes of viral entry into a target cell. Thus, while some viruses (such as Sendai virus
or HIV) fuse directly with the cell plasma membrane at neutral pH, others (such as
influenza virus) enter by receptor-mediated endocytosis. In this case, viral access to
the target cell cytosol occurs following fusion between the viral envelope and the
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membrane of an intracellular compartment (the endosome). For influenza virus this
event is mediated by the viral envelope hemagglutinin (HA), and is triggered by
conformational changes in the protein that take place at the acidic pH normally
found in the endosomal lumen (for reviews see Hoekstra and Lima, 1992; Hernandez
et al., 1996; Ramalho-Santos and Lima, 1998.
The characterization of compounds with putative antiviral activity often focuses
on the ability of these agents to inhibit viral entry by blocking the membrane fusion
step that is necessary for infection (Cheetham et al., 1990; Yeagle et al., 1994;
Gunther-Ausborn et al., 1995; Miao et al., 1995; Epand et al., 1997; Schoen et al.,
1997). One such family of compounds consists of polysulfated molecules, such as
heparin or dextran sulfate, that have attracted attention for their ability to inhibit
HIV replication (for a review see Witvrouw and De Clercq, 1997). For this reason
the effect of polysulfated molecules on the fusion activity of lipid-enveloped viruses
has been studied in many systems, using, among others, both Sendai (Arnold et al.,
1990; Ohki et al., 1991, 1992; Lu¨scher-Mattli et al., 1993; Zscho¨rnig et al., 1993;
Wagner et al., 1998) and influenza viruses (Lu¨scher-Mattli and Glu¨ck, 1990; Herr-
mann et al., 1992; Krumbiegel et al., 1992; Lu¨scher-Mattli et al., 1993), as well as a
wide variety of target membranes.
When determining the effect of inhibitory agents on membrane merging pro-
moted by enveloped viruses, fusion is usually assayed in isolation, and it is therefore
difficult to establish whether inhibition of membrane fusion actually translates into
a reduction of viral infection (Arnold et al., 1990; Ohki et al., 1991, 1992; Herrmann
et al., 1992; Krumbiegel et al., 1992; Zscho¨rnig et al., 1993; Wagner et al., 1998).
Indeed, it is known that inhibition of fusion activity may not correlate with a lower
production of infectious particles (McKenzie et al., 1987; Stamatatos and Du¨zgu¨nes,
1994). On the other hand, while artificial target membranes, such as liposomes, are
useful as models, they do not fully reflect the complexity of a biological membrane,
and extrapolations from these systems must be made with great caution (Lu¨scher-
Mattli and Glu¨ck, 1990; Zscho¨rnig et al., 1993). In fact, target membrane compo-
nents are known to modulate the fusion activity of both Sendai (Nunes-Correia et
al., 1998) and influenza viruses (Lima et al., 1995). Ideally, the effect of any potential
antiviral agent on both fusion and infection should be assayed using the same target
membrane. However, when these experiments are done concomitantly, viral infec-
tivity is usually quantified in live cell monolayers, while membrane merging is moni-
tored using a different target membrane, such as the more readily available
erythrocyte ghosts (Lu¨scher-Mattli et al., 1993).
We have therefore set out to determine the effect of dextran sulfate on the
fusion and infectivity of influenza and Sendai viruses, two lipid-enveloped viruses
with distinct routes of cell entry, using the same target membrane to allow for direct
comparisons. Thus, infection was quantified by plaque formation in MDCK mono-
layers, and, in parallel experiments, viral fusion activity towards the plasma mem-
brane of these cells was also determined using the octadecylrhodamine B chloride
(R18) fluorescence dequenching assay (Hoekstra et al., 1984). For control purposes
erythrocyte ghosts were also occasionally used in fusion experiments as target mem-
branes for both viruses. As was the case in other studies, we separately tested the
effects of two types of dextran sulfate, with distinct molecular weights.
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METHODS
Chemicals
Dextran sulfate of 500 kDa (DS 500) and 5 kDa (DS 5), dextran of 8 kDa (D8)
and 500 kDa (D 500) were obtained from Sigma (St. Louis, MO); as were all other
chemicals used, unless stated otherwise.
Viruses
Influenza virus, APR834 (H1N1) strain, was grown for 48 hr at 37°C in the
allantoic cavity of 11-day-old embryonated eggs, purified by discontinuous sucrose
density gradient centrifugation and stored at A70°C in phosphate buffered saline.
Sendai virus (Z strain) was grown for 72 hr in the allantoic cavity of 10-day-old
embryonated eggs, purified by differential centrifugation and stored at A70°C in
phosphate buffered saline.
Cells
MDCK cells were obtained from the American Type Culture Collection
(ATCC, Rockville, MD) and grown in 75 cm2 culture flasks at 37°C in a humidified
5% CO2 atmosphere with DMEM medium, supplemented with 10% heat-inactivated
fetal calf serum, 100 µml penicillin, 100 µgml streptomycin, 1 gl sodium bicarbon-
ate, 10 mM Hepes (pH 7.4). The medium was changed regularly, and the cells used
when confluent. For fusion experiments MDCK monolayers were washed twice with
calciummagnesium-free PBS, and the cells detached upon incubation (10 min,
37°C) with a trypsin solution containing 138 mM NaCl, 2.7 mM KCl, 1 gl glucose,
0.02% (wv) EDTA, 0.05% (wv) trypsin, 0.58 gl sodium bicarbonate and 10 mM
sodium phosphate (pH 7.4). MDCK cells in suspension were then pelleted (180 g,
10 min), washed twice in PBS and resuspended in the experimental fusion buffer
(110 mM NaCl, 5 mM KCl, 2 mM CaCl2 , 1 mM MgCl2 , 10 mM glucose, 10 mM
sodium citrate, 10 mM Mes and 10 mM Hepes, pH 7.4). Cell viability was deter-
mined by trypan blue exclusion, and was routinely 85–95%. To avoid any possible
effects of cell death or aggregation, all experiments were limited to a maximum of
4 hr following each MDCK cell preparation.
Erythrocyte Ghosts
For control experiments human erythrocyte ghosts were prepared by the
method of Steck and Kant (1974). Following hypotonic lysis the membranes were
resealed in 85 mM NaCl, 50 mM KCl, 5 mM MgCl2 , 10 mM Hepes, 10 mM Mes,
10 mM sodium citrate, buffered at pH 7.4.
Viral Fusion Activity
Influenza and Sendai viruses were labeled with the fluorescent probe octa-
decylrhodamine B chloride (R18; Molecular Probes Inc., Eugene, OR) at a self-
quenching concentration, as described previously (Hoekstra et al., 1984; Ramalho-
Santos et al., 1993, 1996). The final concentration of added probe corresponded to
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approximately 5 mole % of total viral lipid and that of ethanol was less than 1% (v
v). The mixture was incubated in the dark for 30 min at room temperature. R18-
labeled virus was separated from non-inserted fluorophore by chromatography on
Sephadex G-75 (Pharmacia, Uppsala, Sweden) using 150 mM NaCl, 10 mM Hepes,
pH 7.4 as elution buffer. The protein concentration of the labeled virus was deter-
mined by the Lowry assay.
Fusion was monitored continuously at 37°C as a function of R18 fluorescence
dequenching, dependent on probe dilution into the plasma membrane of MDCK
cells upon virus–cell fusion (Hoekstra et al., 1984; Ramalho-Santos et al., 1993,
1996). For influenza virus 2 µg of viral protein were added to 5B106 MDCK cells
in a final volume of 2 ml of experimental buffer at pH 7.4. Following a 2 min incu-
bation the pH was lowered to 5.0, and virus–cell fusion followed for 5 min. For
Sendai virus 5 µg of viral protein were added to 5B106 MDCK cells in a final
volume of 2 ml of experimental buffer at pH 7.4 or 5.0, and virus–cell fusion fol-
lowed for 10 min. Parallel experiments with human erythrocyte ghosts were carried
out in basically the same manner for both viruses, using 100 µg of target membrane
proteinml in each assay.
In some experiments we sought to evaluate exclusively the fusion activity of
bound virions. For this purpose influenza (3 µg) and Sendai (15 µg) viruses were
incubated with 5B106 MDCK cells for 1 hr at 0°C and pH 7.4. The virus–cell mix-
ture was then pelleted (180 g, 10 min, 0°C), washed twice and resuspended in a small
volume (±100 µl ) of experimental buffer. This cell pellet was added to 1.9 ml of
buffer at 37°C, and fusion of bound virus monitored for 5 min at pH 5.0
(influenza), or 10 min at pH 7.4 or 5.0 (Sendai).
In all experiments the fluorescence scale was calibrated such that the initial
fluorescence of R18 labeled virus and cells was set at 0% fluorescence, and the value
obtained by detergent lysis after each experiment with Triton X-100 (maximal probe
dilution), at a final concentration of 1% (vv), was set at 100% fluorescence. Fluor-
escence measurements were performed in a SPEX Fluorolog spectrofluorometer,
with excitation at 560 nm and emission at 590 nm. The sample chamber was
equipped with a magnetic stirring device, and the temperature was maintained at
37°C with a thermostatted circulating water bath.
Binding and Cell Association
To quantify virus–cell binding, influenza virus (2 µg of viral protein) was added
to 5B106 MDCK cells in a final volume of 2 ml. The virus–cell suspension was then
incubated at 37°C and pH 7.4 for 2 min. For Sendai virus 5 µg of viral protein were
added to 5B106 MDCK cells in a final volume of 2 ml and the mixture incubated
for 1 hr at 0°C and pH 7.4 or 5.0. Under these conditions fusion does not take place.
Following these incubations the cells were centrifuged (180 g, 10 min, 0°C) and
fluorescence measured in the pellet and supernatant after addition of Triton X-100
(1% vv). Binding was calculated as the percentage of fluorescence in the pellet,
relative to total fluorescence (pelletCsupernatant). Cell association (boundCfused
virions) was also measured for influenza virus. In this case the virus–cell incubation
at pH 7.4 was followed by a further 5 min incubation at pH 5.0 (37°C). The cells
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were then centrifuged (180 g, 10 min, 0°C), and cell association calculated as
described above (Lima et al., 1995).
Viral Infectivity
Infectivity was determined as described previously (Compans and Roberts,
1994). Briefly, MDCK cells were grown to confluency in 12-compartment multiwells
and incubated for 2 hr (37°C) with 0.5 ml of socially diluted viral suspensions in
PBS. The cells were then washed twice in PBS to remove unbound virions, overlayed
with 1 ml of agar (1 % wv) in DMEM containing 5 µgml trypsin, and returned to
the incubator. Plaques were counted 2–5 days post infection. In experiments using
dextran or dextran sulfate the agents were present at a fixed concentration through-
out the experiment.
RESULTS
Inhibition of Influenza Virus Fusion Activity by Dextran Sulfate
The effect of DS 500 and DS 5 on influenza virus fusion activity towards the
plasma membrane of MDCK cells was determined. When added to the fusion
medium prior to the low pH triggering of influenza fusion, dextran sulfate inhibited
membrane merging (Fig. 1). The higher molecular weight DS 500 was noticeably
more potent, reducing fusion at a concentration as low as 5 µgml, and inhibiting
the process by a maximum ofJ73%. On the other hand, an effect of DS 5 was only
detected at 15 µgml, and the inhibition obtained with this lower molecular weight
dextran sulfate was never above J41%. Interestingly, with both types of dextran
sulfate some (none negligible) influenza virus fusion activity was always maintained;
i.e., membrane merging could not be inhibited below a certain value, characteristic
for each type of DS (Fig. 1). This inhibition was specific for these sulfated com-
pounds, since the presence of equivalent concentrations of D 8 or D 500 in the
medium had no effect on viral fusion activity (data not shown). On the other hand,
inhibition by dextran sulfate (both DS 500 and DS 5) was similar when erythrocyte
ghosts were used as target membranes in the fusion assay (data not shown). The
inhibitory effect was not enhanced by preincubating virions or cells with dextran-
sulfate, which was equally potent (with DS 500 always showing a greater inhibitory
effect) towards prebound virons (data not shown).
Virus–cell interactions were clearly affected by dextran sulfate only at low pH.
Viral binding (at neutral pH) did not change in the presence or absence of the agents,
while cell association was greatly reduced, again DS 500 showing an increased inhibi-
tory effect when compared to DS 5 (Table 1). Remarkably, DS 500 reduced cell
association to a value below what was observed for binding, suggesting that this
compound might cause some viral dissociation.
Often overlooked is the fact that characterization of any new fusion system
studied with the R18 assay should involve careful controls, to determine if any non-
specific probe transfer takes place from the virions to the target membranes, leading
to a false positive signal. This is accomplished by proving that the virus can be
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Fig. 1. Effect of dextran sulfate on the fusion activity of influenza virus. R18-
labeled influenza virus (1 µg viral proteinml) was added to 5B106 MDCK cells
at 37°C and pH 7.4. The medium also contained DS 500 or DS 5 at the indicated
concentrations (µgml). Following a short period of incubation to allow virus–
cell binding (2 min) the medium pH was adjusted to 5.0, and the extent of R18
dequenching calculated after 5 min. The average JSD of 6 independent experi-
ments is presented. Higher concentrations of dextran sulfate had no further
inhibitory effect (data not shown).
maintained in close contact with the target membrane (i.e., bound) without major
R18 dequenching, at least in the time frame used for the assay. For this purpose,
influenza virions were irreversibly inactivated by preincubation (1 hr, 37°C, pH 5.0)
in the absence of target membranes. This treatment precociously triggers the con-
formation change in the viral HA, and renders the virions fusion-incompetent
(Ramalho-Santos et al., 1993, 1996; Ramalho-Santos and Lima, 1998). Inactivated
Table 1. Effect of Dextran Sulfate on Influenza Virus Binding and Cell Association to
MDCK Cellsa
pH Control DS 500 DS 5
Binding (%) 7.4 32.6J1.9 31.6J1.3 32.3J1.5
Cell Association (%) 7.45.0 55.0J2.0 25.0J1.1 33.2J2.2
aR18-labeled influenza virus (2 µg) was added to 5B106 MDCK cells, in a final volume
of 2 ml at 37°C. Virus–cell binding was quantified following a 2 min incubation at
pH 7.4. In cell association experiments, following the incubation at neutral pH the
medium was acidified, and the mixture further incubated at pH 5.0 for 5 min (see
Methods). In some experiments DS 500 and DS 5 were also included (15 µgml). The
average of at least 3 independent experiments (±SD) is presented. Higher concen-
trations of dextran sulfate had no further effect (data not shown).
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virions were still able to bind to MDCK cells (29.8J1.8) and the value obtained
was essentially identical to that of controls assayed simultaneously (31.1J1.3). On
the other hand, inactivated influenza virus only showed residual fusion activity (less
than 8%, data not shown), thus suggesting that unspecific R18 transfer does not
affect the observations in this fusion system.
Inhibition of Sendai Virus Fusion by Dextran Sulfate
Fusion of Sendai virus with MDCK cells was maximal at pH 7.4 (data not
shown), similarly to what is observed when other biological target membranes are
used (Ohki et al., 1991, 1992; Lima et al., 1992). However, at neutral pH the presence
of DS 5 and DS 500 in the medium had no effect on viral fusion activity (data not
shown). This result was obtained when the compounds were added shortly before
the virions, and when either fusion partner was incubated with dextran sulfate prior
to fusion (data not shown). Although Sendai virus fusion activity was much lower
(∼14.2%) at pH 5.0 than at pH 7.4 (∼32.9%), viral fusion at acidic pH was inhibited
by both DS 5 and DS 500 (Fig. 2). Despite the fact that the concentrations required
to observe any inhibitory effect were higher than for influenza virus, the pattern was
otherwise very similar. Namely, the effect was more pronounced for DS 500 (maxi-
mum inhibition of ∼66%) than for DS 5 (maximum inhibition of ∼33%), and a mini-
mal residual fusion activity was maintained even at high dextran sulfate
Fig. 2. Effect of dextran sulfate on the fusion activity of Sendai virus at
low pH. R18-labeled Sendai virus (5 µg viral proteinml) was added to
5B106 MDCK cells at 37°C and pH 5.0. The medium also contained
DS 500 or DS 5 at the indicated concentrations (µgml). Fusion extents, as
monitored by R18 dequenching, were calculated after 10 min, and the aver-
ageJSD of 5 independent experiments is presented. Higher concentrations
of dextran sulfate had no further inhibitory efect (data not shown).
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Fig. 3. Effect of dextran sulfate on the fusion activity of Sendai virus prebound
to MDCK cells. R18-labeled Sendai virus (15 µg viral proteinml) was added to
2 ml of buffer containing 5B106 MDCK cells at 0°C and pH 7.4. Following a
1 hr incubation at 0°C the cells were pelleted, and the fusion activity of bound
virions was assayed at pH 7.4 or 5.0, in the presence or absence of dextran sulfate
(0.5 mgml). Fusion extents, as monitored by R18 dequenching, were calculated
after 10 min, and the average JSD of 6 independent experiments is presented.
concentrations. Inhibition was also not enhanced by preincubating virions or cells
with dextran sulfate (data not shown), and the inhibitory effect of dextran sulfate
towards prebound Sendai virions was similar (Fig. 3), although in this case a slight
decrease in fusion activity (∼18%) was observed with DS 500 at pH 7.4.
Binding of Sendai virus to MDCK cells was greatly potentiated at low pH
(Table 2). This is most likely an unspecific effect, probably due to an increase in
viral hydrophobicity (Ramalho-Santos et al., 1994a, b), since it does not translate
Table 2. Effect of pH and Dextran Sulfate on Binding
of Sendai Virus to MDCK Cellsa
pH Control DS 500 DS 5
7.4 23.9J1.8 23.4J1.2 23.3J1.7
5.0 42.3J1.9 19.2J1.4 34.8J1.1
aR18-labeled Sendai virus (5 µg) was added to 5B106
MDCK cells at 0°C and pH 7.4 or 5.0. In some experi-
ments DS 500 or DS 5 (0.5 mgml) were also included.
Binding percentage was determined after a 1 hr incu-
bation (see Methods). The average of at least 3 inde-
pendent assays (±SD) is presented. Higher
concentrations of dextran sulfate had no further effect
(data not shown).
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into a higher fusion activity at pH 5.0 (see above). Dextran sulfate modulated viral
binding in a manner that mirrored its efect on fusion; i.e., binding at neutral pH
was unaffected, while binding at pH 5.0 was inhibited by DS 500 and, with less
potency, by DS 5 (Table 2).
Other experiments demonstrated that the presence of equivalent concentrations
of D 8 and D 500 in the medium did not affect Sendai virus fusion with MDCK
cells in any way (data not shown). In addition, Sendai virus pretreated with trypsin
before being added to MDCK cells was still able to bind the target membrane, but
could no longer fuse with it (at both pH 7.4 and 5.0). Therefore, it seems reasonable
to conclude that increases in R18 fluorescence monitored in these assays were due
to membrane fusion, and not to non-specific probe transfer (data not shown). Finally,
it should be noted that inhibition of Sendai virus fusion activity by dextran sulfate
(both DS 500 and DS 5) was similar when erythrocyte ghosts were used as target
membranes (data not shown).
Effect of Dextran Sulfate on Influenza and Sendai Virus Infectivity
The effect of dextran sulfate on viral replication was determined as a function
of infectivity in MDCK monolayers, monitored with the plaque assay. In this man-
ner fusion and infection are quantified using the same target membranes. However,
inhibition of viral replication by dextran sulfate only occurred for influenza virus,
notably using DS 500, while Sandai virus infectivity was unaffected in the presence
of the polysulfated anions (Table 3).
Table 3. Effect of Dextran Sulfate on the





DS 500 (15 µgml) 4.0B106
DS 5 (15 µgml) 2.2B107
Sendai
Control 8.1B106
DS 500 (0.5 mgml) 8.3B106
DS 5 (0.5 mgml) 7.9B106
aViral infectivity was determined as described in
Methods. In all cases dextran sulfate was added
to the cells before the virus, and maintained in
the culture medium throughout. Higher concen-
trations of dextran sulfate (up to 100 µgml for
influenza, and 2 mgml in the case of Sendai)
did not further inhibit viral infectivity (data not
shown). The presence of equivalent concen-
trations of dextran (both D 8 and D 500) had no
effect (data not shown). Representative data
from 4 independent experiments is presented.
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DISCUSSION
In this study we have directly and systematically compared the fusion activity
and infection of influenza and Sendai viruses as affected by two types of dextran
sulfate, using MDCK cells as viral targets. The results obtained are consistent with
previously published data regarding the effect of these polyanions on virus fusion
(Arnold et al., 1990; Lu¨scher–Mattli and Glu¨ck, 1990; Ohki et al., 1991, 1992;
Herrmann et al., 1992; Krumbiegel et al., 1992; Lu¨scher-Mattli et al., 1993;
Zscho¨rnig et al., 1993; Wagner et al., 1998). In addition, some new information has
also emerged.
Inhibition of membrane fusion in our system was always much more pro-
nounced with DS 500 than DS 5, in agreement with a previous study for influenza
virus (Krumbiegel et al., 1992), but in contrast to the modest differences reported in
other systems, using either virus and dextran sulfate of different molecular weights
(Lu¨scher-Mattli and Glu¨ck, 1990; Ohki et al., 1991; Lu¨scher-Mattli et al., 1993;
Zscho¨rnig et al., 1993). Dextran sulfate seemed to affect even virions that had been
previously bound to MDCK cells, and the effect of the polysulfated molecules was
almost exclusively dependent on the acidic pH of the medium (see below). For both
viruses a residual fusion activity was always observed, and even high concentrations
of dextran sulfate could not totally abolish, or even further reduce, membrane merg-
ing. Furthermore, in all cases this residual fusion was always higher for DS 5 than
DS 500, i.e., even higher concentrations of DS 5 did not cause the same inhibitory
effect as DS 500. Given that dextran sulfate has been suggested to bind to viral
membranes (Lu¨scher-Mattli and Gluck, 1990; Ohki et al., 1991, 1992), this result
indicates that there may be a limited number of binding sites for dextran sulfate on
the viral envelope. Since dextran sulfate does not seem to affect the low pH-depen-
dent conformational change of the influenza HA (Krumbiegel et al., 1992), or inter-
act directly with Sendai virus envelope proteins (Zscho¨rnig et al., 1993), polysulfated
molecules bound to the virions might inhibit membrane merging by acting as a steric
barrier to the final approach, which would also explain why the larger DS (DS 500)
has always a significantly greater effect than DS 5. Although dextran sulfate has
been suggested to inhibit virus-cell binding (Herrmann et al., 1992), this effect prob-
ably has little physiological relevance, given that both viruses usually bind a target
cell at neutral pH (Hoekstra and Lima, 1992; Ramalho-Santos and Lima, 1998),
and that this interaction is not affected in the presence of dextran sulfate.
In previous studies dextran sulfate was shown to inhibit Sendai virus fusion
activity at neutral pH, although the effect was always much more pronounced at
low pH (Ohki et al., 1991, 1992). One difference in the experimental approach is
that our fusion media contained divalent cations, which could interact with dextran
sulfate, and possibly affect its potency. However, this seems unlikely, since 2 mM
CaCl2 does not diminish the effect of dextran sulfate on the binding and fusion of
influenza virus with erythrocyte ghosts (Krumbiegel et al., 1992). Furthermore, in
our system dextran sulfate has an inhibitory effect at low pH similar to what has
been reported with divalent cation-free media (Ohki et al., 1991, 1992). Curiously,
this inhibition is in the same range as the effect observed for influenza virus. It has
been suggested that acidification neutralizes negative charges on the virus surface,
Inhibition of Viral Fusion and Infectivity 303
thus enhancing binding of the negatively charged dextran sulfate (Lu¨scher-Mattli
and Glu¨ck, 1990; Ohki et al., 1991, 1992; Wagner et al., 1998). Indeed, as mentioned
above, dextran sulfate only inhibited influenza or Sendai virus interactions with
MDCK cells at low pH. However, while in the case of influenza this effect may be
important in terms of viral infection, the same cannot be stated for Sendai virus. In
this regard it is important to note that, while Sendai virus binds more avidly to
target membranes at low pH, a process also inhibited by dextran sulfate, this is
probably due to an unspecific increase in viral hydrophobicity (Ramalho-Santos et
al., 1994a, b). Moreover, increased binding at a physiologically relevant low pH only
translates into a higher fusion activity when negatively charged liposomes (Zscho¨rnig
et al., 1993), rather than biological membranes (this study, see also Ohki et al., 1991,
1992; Lima et al., 1992), are used as targets.
Inhibition of influenza virus fusion activity by DS 5 and DS 500 could be
directly correlated with viral infection, which was expected, since this virus requires
a low pH step to enter target cells (Lu¨scher-Mattli et al., 1993). On the other hand,
given that Sendai virus fuses directly with the cell plasma membrane at neutral pH,
it was not forseeable that DS 500 or DS 5 would inhibit viral entry in ûiûo, and that
was indeed the case (Lu¨scher–Mattli et al., 1993). It seems reasonable to assume
that, for an agent such as dextran sulfate to potently inhibit viral infectivity, it must
severely hinder viral fusion. Thus, it is unlikely that even the relatively modest effects
of dextran sulfate on the fusion of Sendai virus at neutral pH reported previously
(Ohki et al., 1991, 1992), would translate into an effective inhibition of infectivity.
It is therefore probable that modulation of Sendai virus fusion activity by dextran
sulfate, although important in addressing questions related to the viral fusion
activity itself (Arnold et al., 1990; Ohki et al., 1991, 1992; Zscho¨rnig et al., 1993;
Wagner et al., 1998), has little relevance in terms of inhibiting cell infection by
this virus, an observation that might be extrapolated to other members of the
paramyxovirus family.
Finally, since the effect of dextran sulfate on membrane fusion was similar when
MDCK cells and erythrocyte ghosts were used as target membranes, it is reasonable
to assume that the more readily available ghosts are good models to predict the
potency of antiviral agents that affect viral fusion activity. Infectivity quantified in
cell monolayers and fusion monitored using erythrocyte membranes (Lu¨scher-Mattli
et al., 1993) are therefore valid experimental approaches to correlate viral infection
and membrane merging.
ACKNOWLEDGMENTS
This work was supported by FCT (Portugal).
REFERENCES
Arnold, K., Flanagan, T. D., and Ohki, S. (1990) Biomed. Biochim. Acta 49:633–635.
Cheetham, J. J., Epand, R. M., Andrews, M., and Flanagan, T. D. (1990) J. Biol. Chem. 265:12404–
12409.
Compans, R. W. and Roberts, P. C. (1994) Methods Cell Biol. 43:3–42.
304 Ramalho-Santos and Pedroso de Lima
Epand, R. F., Moroder, L., Lutz, J., Flanagan, T. D., Nir, S., and Epand, R. M. (1997) Biochim. Biophys.
Acta 1327:259–268.
Gunther-Ausborn, S., Praetor, A., and Stegmann, T. (1995) J. Biol. Chem. 270:29279–29285.
Hernandez, L. D., Hoffmann, L. R., Wolfsberg, T. G., and White, J. (1996) Annu. Reû. Cell Deû. Biol.
12:627–661.
Herrmann, A., Korte, T., Arnold, K., and Hillebrecht, B. (1992) Antiûiral Res. 19:295–311.
Hoekstra, D., de Boer, T., Klappe, K., and Wilschut, J. (1984) Biochemistry 23:5675–5681.
Hoekstra, D. and Lima, M. C. P. (1992) Adû. Memb. Fluid. 6:71–97.
Krumbiegel, M., Dimitrov, D. S., Puri, A., and Blumenthal, R. (1992) Biochim. Biophys. Acta 1110:
158–164.
Lima, M. C. P., Ramalho-Santos, J., Martins, M. F., Carvalho, A. P., Bairos, V., and Nir, S. (1992) Eur.
J. Biochem. 205:181–186.
Lima, M. C. P., Ramalho-Santos, J., Flasher, D., Slepushkin, V. A., Nir, S., and Du¨zgu¨nes, N. (1995)
Biochim. Biophys. Acta 1236:323–330.
Lu¨scher-Mattli, M. and Glu¨ck, R. (1990) Antiûiral Res. 14:39–50.
Lu¨scher-Mattli, M., Glu¨ck, R., Kempf, C., and Zanoni-Grassi, M. (1993) Arch. Virol. 130:317–326.
McKenzie, R. C., Epand, R. M., and Johnson, D. C. (1987) Virology 159:1–9.
Miao, L., Stafford, A., Nir, S., Turco, S. J., Flanagan, T. D., and Epand, R. M. (1995) Biochemistry
34:4676–4683.
Nunes-Correia, I., Ramalho-Santos, J., and Lima, M. C. P. (1998) Biosci. Rep. 18:
59–68.
Ohki, S., Arnold, K., Srinivasakumar, N., and Flanagan, T. D. (1991) Biomed. Biochim. Acta 50:199–
206.
Ohki, S., Arnold, K., Srinivasakumar, N., and Flanagan, T. D. (1992) Antiûiral Res. 18:163–177.
Ramalho-Santos, J., Nir, S., Du¨zgu¨nes, N., Carvalho, A. P., and Lima, M. C. P. (1993) Biochemistry
32:2771–2779.
Ramalho-Santos, J., Negra˜o, R., and Lima, M. C. P. (1994a) Biochem. Mol. Biol. Inter. 32:1121–1127.
Ramalho-Santos, J., Negra˜o, R., and Lima, M. C. P. (1994b) Biosci. Rep. 14:15–24.
Ramalho-Santos, J., Lima, M. C. P., and Nir, S. (1996) J. Biol. Chem. 271:23902–23906.
Ramalho-Santos, J. and Lima, M. C. P. (1998) Biochim. Biophys. Acta 1376:147–154.
Schoen, P., Corver, J., Meijer, D. K., Wilschut, J., and Swart, P. J. (1997) Biochem. Pharmacol. 53:
995–1003.
Stamatatos, L. and Du¨zgu¨nes, N. (1994) J. Gen. Virol. 74:1043–1054.
Steck, T. L. and Kant, J. A. (1974) Methods Enzymol. 31:172–180.
Wagner, M., Flanagan, T. D., and Ohki, S. (1998) Antiûiral Res. 39:113–127.
Witvrouw, M. and De Clercq, E. (1997) Gen. Pharmacol. 29:497–511.
Yeagle, P. L., Smith, F. T., Young, J. E., and Flanagan, T. D. (1994) Biochemistry 33:1820–1827.
Zscho¨rnig, O., Arnold, K., and Ohki, S. (1993) Biochim. Biophys. Acta 1148:1–6.
